Are Prognostic Factors the Same for Non-Invasive and Invasive Local Recurrence (LR) in Patients with Ductal Carcinoma In Situ (DCIS) Treated with Breast-Conserving Therapy (BCT)?

被引:0
|
作者
Collins, L.
Achacoso, N.
Haque, R.
Nekhlyudov, L.
Fletcher, S.
Quesenberry, C.
Schnitt, S.
Habel, L.
机构
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Kaiser Permanente, Oakland, CA USA
[3] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
131
引用
收藏
页码:34A / 34A
页数:1
相关论文
共 50 条
  • [1] Are Prognostic Factors the Same for Non-Invasive and Invasive Local Recurrence (LR) in Patients with Ductal Carcinoma In Situ (DCIS) Treated with Breast-Conserving Therapy (BCT)?
    Collins, L.
    Achacoso, N.
    Haque, R.
    Nekhlyudov, L.
    Fletcher, S.
    Quesenberry, C.
    Schnitt, S.
    Habel, L.
    LABORATORY INVESTIGATION, 2011, 91 : 34A - 34A
  • [2] Invasive Lobular Carcinoma (ILC) of the Breast: Local Recurrence (LR) After Breast-Conserving Therapy (BCT) by Subtype Approximation
    Braunstein, L. Z.
    Brock, J. E.
    Chen, Y.
    Truong, L.
    Russo, A. L.
    Arvold, N. D.
    Harris, J. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S243 - S244
  • [3] Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ
    Laura C. Collins
    Ninah Achacoso
    Reina Haque
    Larissa Nekhlyudov
    Suzanne W. Fletcher
    Charles P. Quesenberry
    Stuart J. Schnitt
    Laurel A. Habel
    Breast Cancer Research and Treatment, 2013, 139 : 453 - 460
  • [4] Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ
    Collins, Laura C.
    Achacoso, Ninah
    Haque, Reina
    Nekhlyudov, Larissa
    Fletcher, Suzanne W.
    Quesenberry, Charles P., Jr.
    Schnitt, Stuart J.
    Habel, Laurel A.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (02) : 453 - 460
  • [5] The presence of lobular carcinoma in situ (LCIS) does not increase local recurrence (LR) in patients treated with breast-conserving therapy (BCT)
    Ciocca, R. M.
    Li, T.
    Freedman, G.
    Morrow, M.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 24 - 25
  • [6] Correlation of concurrent lobular neoplasia (LN) and ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ (DCIS) treated with breast-conserving therapy (BCT)
    Rudloff, U.
    Brogi, E.
    Brockway, J. P.
    Wynveen, C. A.
    Nehhozina, T.
    Reiner, A.
    Patil, S.
    Van Zee, K. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Predictors of Local Recurrence (LR) in Patients with Ductal Carcinoma In Situ (DCIS) Treated by Breast Conserving Therapy (BCT): Value of the Memorial Sloan-Kettering (MSK) Nomogram
    Collins, L. C.
    Achacoso, N.
    Sharafali, Z.
    Haque, R.
    Nekhlyudov, L.
    Fletcher, S. W.
    Quesenberry, C. P.
    Habel, L. A.
    Schnin, S. J.
    MODERN PATHOLOGY, 2012, 25 : 31A - 31A
  • [8] Impact of surgery-to-radiotherapy interval (SRI) on local control in patients with ductal carcinoma in situ (DCIS) treated with breast-conserving therapy (BCT)
    Thurman, SA
    Schnitt, SJ
    Connolly, JL
    Gelman, R
    Silver, B
    Harris, JR
    Recht, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S382 - S383
  • [9] BREAST-CONSERVING THERAPY FOR INVASIVE-CARCINOMA - DIAGNOSIS OF LOCAL RECURRENCE
    RUTGERS, EJT
    VANROSSUM, AB
    PETERSE, JL
    COHEN, P
    BORGER, JH
    KEMPERMAN, HWPM
    NETHERLANDS JOURNAL OF SURGERY, 1991, 43 (04): : 110 - 113
  • [10] Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy
    Swarnkar, Parinita K.
    Mokbel, Kefah
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (03) : 919 - 920